1. A Markov model of the cost-effectiveness of human-derived follicle-stimulating hormone (FSH) versus recombinant FSH using comparative clinical trial data 
Hind T. Hatoum, Ph.D., William R. Keye, M.D., Richard P. Marrs, M.D., Surrey M. Walton, Ph.D., Dennis C. Marshall, R.N., M.S., Ph.D. 
Fertility and Sterility 
Volume 83, Issue 3, Pages (March 2005)
DOI: /j.fertnstert
Copyright © 2005 American Society for Reproductive Medicine Terms and Conditions

2. FIGURE 1
Outline of Markov model illustrating transition between health states for each treatment cycle. OHSS = ovarian hyperstimulation syndrome.
Fertility and Sterility  , DOI: ( /j.fertnstert )
Copyright © 2005 American Society for Reproductive Medicine Terms and Conditions